BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ebrahimi S, Teimoori A, Khanbabaei H, Tabasi M. Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome. Rev Med Virol 2019;29:e2009. [PMID: 30260068 DOI: 10.1002/rmv.2009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Haddad CO, Kalt I, Shovman Y, Xia L, Schlesinger Y, Sarid R, Parnas O. Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells. Virol J 2021;18:56. [PMID: 33731154 DOI: 10.1186/s12985-021-01527-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gowripalan A, Smith S, Stefanovic T, Tscharke DC. Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool. Commun Biol 2020;3:643. [PMID: 33144673 DOI: 10.1038/s42003-020-01374-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Kong X, Cheng R, Wang J, Fang Y, Hwang KC. Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications. Nano Today 2021;36:101004. [DOI: 10.1016/j.nantod.2020.101004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ebrahimi S, Makvandi M, Abbasi S, Azadmanesh K, Teimoori A. Developing oncolytic Herpes simplex virus type 1 through UL39 knockout by CRISPR-Cas9. Iran J Basic Med Sci 2020;23:937-44. [PMID: 32774817 DOI: 10.22038/ijbms.2020.43864.10286] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Hu H, Pan K, Shang Y, Guo Y, Xiao H, Deng F, Wang M, Hu Z. Multiloci Manipulation of Baculovirus Genome Reveals the Pivotal Role of Homologous Regions in Viral DNA Replication, Progeny Production, and Enhancing Transcription. ACS Synth Biol 2022;11:144-53. [PMID: 34933547 DOI: 10.1021/acssynbio.1c00303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Jamehdor S, Pajouhanfar S, Saba S, Uzan G, Teimoori A, Naserian S. Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions. Cells 2022;11:999. [PMID: 35326449 DOI: 10.3390/cells11060999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Teng M, Yao Y, Nair V, Luo J. Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development. Viruses 2021;13:779. [PMID: 33924851 DOI: 10.3390/v13050779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yin L, Zhao F, Sun H, Wang Z, Huang Y, Zhu W, Xu F, Mei S, Liu X, Zhang D, Wei L, Cen S, Hu S, Liang C, Guo F. CRISPR-Cas13a Inhibits HIV-1 Infection. Mol Ther Nucleic Acids 2020;21:147-55. [PMID: 32585623 DOI: 10.1016/j.omtn.2020.05.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
9 Liao Y, Bajwa K, Reddy SM, Lupiani B. Methods for the Manipulation of Herpesvirus Genome and the Application to Marek's Disease Virus Research. Microorganisms 2021;9:1260. [PMID: 34200544 DOI: 10.3390/microorganisms9061260] [Reference Citation Analysis]
10 Lin H, Li G, Peng X, Deng A, Ye L, Shi L, Wang T, He J. The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses. Front Cell Infect Microbiol 2021;11:590989. [PMID: 34513721 DOI: 10.3389/fcimb.2021.590989] [Reference Citation Analysis]